{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "MCH antagonists and their use in the treatment of obesity", "item": "https://www.patentleaderboard.com/patent/7452891"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MCH antagonists and their use in the treatment of obesity

MCH antagonists and their use in the treatment of obesity

US Patent 7452891 · Granted Nov 18, 2008

Estimated economic value: $148,890,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Small molecule inhibitors of KRAS G12C mutant2025
Small molecule inhibitors of KRAS G12C mutant2025
Arginase inhibitors and methods of use2025
Arginase inhibitors and methods of use2025
PCSK9 antagonist compounds2025
PCSK9 antagonist compounds2024
Small molecule inhibitors of KRAS G12C mutant2023
Long-acting co-agonists of the glucagon and GLP-1 receptors2023
Long-acting co-agonists of the glucagon and GLP-1 receptors2022
PCSK9 antagonist compounds2022
PCSK9 antagonist compounds2022
PCSK9 antagonists bicyclo-compounds2022